Natco Pharma Ltd. — Capital/Financing Update 2019

Jan 25, 2019

==> picture [452 x 45] intentionally omitted <==

25[th] January, 2019

Corporate Relationship Department Manager – Listing M/s. BSE Ltd. M/s. National Stock Exchange of India Ltd Dalal Sreet, Fort “Exchange Plaza”, Bandra – Kurla Complex Mumbai 400 001 Bandra (E) Mumbai 400 051 Scrip Code: 524816 Scrip Code: NATCOPHARM

Dear Sir

Please find enclose herewith the Press Release for your information.

Thanking you

Yours faithfully For NATCO Pharma Limited

==> picture [106 x 23] intentionally omitted <==

M. Adinarayana Company Secretary & Vice President (Legal and Corp Affairs

Press Release

==> picture [452 x 45] intentionally omitted <==

Ref:PR/9/2019

NATCO initiates Greenfield Facilities for Niche Agrichemical Business

Hyderabad, India, January 25[th] , 2019

Natco Pharma Limited (NSE: NATCOPHARM; BSE: 524816) has initiated work on green-field manufacturing facilities for producing Niche Agrichemical products in the Nellore District of Andhra Pradesh. These facilities will manufacture both Agrichemical Technical and Formulation products.

Natco strongly believes that its pharma strength in chemistry coupled with an acumen towards selection of niche molecules would differentiate itself in the Agrichemical space as well. Natco expects the facilities in Nellore district to be commissioned by end of 2019 with a total capital expenditure of INR 100 crores.

---

Forwarded for favor of publication

For NATCO Pharma Limited

==> picture [107 x 23] intentionally omitted <==

M. Adinarayana Company Secretary & Vice President (Legal and Corp Affairs)